StockTipsArenaBeta

BUY CREDITACCESS GRAMEEN LIMITED — Nomura India Research

BUYCREDITACCESS GRAMEEN LIMITED
CREDITACCESS GRAMEEN share price target & all analyst calls

byNomura India ResearchHorizon: NA (inferred 1 year)23 Oct 2026via CNBC Awaaz.

Entry₹1,140.9Inferred
Target₹1,700
Total upside +49.01%
Stop lossNot given
CMP₹1,035Just now
Active-9.28%+64.25%upside left 12 mo left
Follow Nomura India Research for new calls(100% target hit, 24 closed calls)Get alertsWatch CREDITACC for new buy/sell callsGet alertsSee 14 other Long-term calls on CREDITACCSee 253 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 12:51 pm IST
19 supporting2 neutral1 opposing
Supports the BUY call (19)

From Havells To Cyient Q2 Results Review: HDFC Securities Sees Up To 74% Upside; Check Target Prices

NewsNdtv-Profit·23 Oct · today

(opens in new tab)

CreditAccess Grameen Q2 Results: Profit jumps 4-fold as credit costs fall 43%; FY27 guidance raised

NewsCnbc-Tv18·22 Oct · today

(opens in new tab)

CreditAccess Grameen Q2 profit jumps fourfold to Rs 502 crore

NewsEt-Markets·22 Oct · today

(opens in new tab)

CreditAccess Grameen reported strong Q2 FY27 results with PAT growing 298.7% YoY to INR 501.6 crore and AUM increasing 19.5% YoY to INR 30,946 crore. The company also raised its FY27 ROA and ROE guida

NSE · Press Release·22 Oct · today

(opens in new tab)

CreditAccess Grameen reported Q2 FY27 PAT of INR 502 crore, up 298.7% YoY, and raised its FY27 guidance for ROA to 5.2-5.8% and ROE to 21-24%.

BSE · Company Update·22 Oct · today

(opens in new tab)
Neutral / worth noting (2)

CREDITACCESS GRAMEEN LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·22 Oct · today

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on CREDITACCESS GRAMEEN

All analyst calls on CREDITACCESS GRAMEEN

More from Nomura India Research

Every call and its outcome